PoC Trial. Each PoC Trial will be conducted in accordance with the PoC Trial Design set forth in the applicable Development Plan. Isis will keep Biogen Idec informed of the progress and status of each PoC Trial. When Isis [***] a PoC Trial under the applicable Development Plan, Isis will notify Biogen Idec in writing within 30 days after such measurement. Isis will provide Biogen Idec with the [***] as soon as practicable after such notice. If Biogen Idec exercises its Option prior to the Initiation of the first PoC Trial for a Collaboration Program, Biogen Idec will keep Isis informed of the progress and status of the PoC Trial for such Collaboration Program. When Biogen Idec completes such PoC Trial, Biogen Idec will notify Isis in writing within 30 days after such completion, and will provide Isis with [***] as soon as practicable after such notice.
Appears in 1 contract
PoC Trial. Each The PoC Trial will be conducted designed in accordance with the PoC Trial Design set forth in the applicable Development ISIS-DMPKRx R&D Plan. Isis will keep Biogen Idec informed of the progress and status of each the PoC Trial. When Isis [***] a completes the PoC Trial under the applicable Development ISIS-DMPKRx R&D Plan, Isis will notify Biogen Idec in writing within 30 days after such measurementcompletion. Isis will provide Biogen Idec with the [***] as soon as practicable after such notice. If Biogen Idec exercises its the Option prior to the Initiation of the first PoC Trial for a Collaboration ProgramTrial, Biogen Idec will keep Isis informed of the progress and status of the PoC Trial for such Collaboration ProgramTrial. When Biogen Idec completes such the PoC Trial, Biogen Idec will notify Isis in writing within 30 days after such completion, and will provide Isis with [***] as soon as practicable after such notice.
Appears in 1 contract
Sources: DMPK Research, Development, Option and License Agreement (Isis Pharmaceuticals Inc)